BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38638429)

  • 1. Immunoglobulin-like transcript 2 as an impaired anti-tumor cytotoxicity marker of natural killer cells in patients with hepatocellular carcinoma.
    Sakata T; Yoshio S; Yamazoe T; Mori T; Kakazu E; Aoki Y; Aoyanagi N; Okamoto T; Ito T; Toyoda H; Kawaguchi T; Ono Y; Takahashi Y; Taketomi A; Kanto T
    Front Immunol; 2024; 15():1389411. PubMed ID: 38638429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased ILT2 expression contributes to dysfunction of CD56
    Zhang Y; Tong S; Li S; Wang X; Ren H; Yin W
    Antiviral Res; 2022 Sep; 205():105385. PubMed ID: 35917968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic Characterization by Single-Cell Mass Cytometry of Human Intrahepatic and Peripheral NK Cells in Patients with Hepatocellular Carcinoma.
    Yoshida Y; Yoshio S; Yamazoe T; Mori T; Tsustui Y; Kawai H; Yoshikawa S; Fukuhara T; Okamoto T; Ono Y; Takahashi Y; Hashida R; Kawaguchi T; Taketomi A; Kanto T
    Cells; 2021 Jun; 10(6):. PubMed ID: 34198593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased frequency of ILT2-expressing CD56(dim)CD16(+) NK cells correlates with disease severity of pulmonary tuberculosis.
    Wang X; Meng X; Zheng Y; Jiang J; Yang B; Liu Y; Zhai F; Cheng X
    Tuberculosis (Edinb); 2014 Sep; 94(5):469-74. PubMed ID: 24909369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Frequency of Dysfunctional Siglec-7
    Sakamoto Y; Yoshio S; Doi H; Mori T; Matsuda M; Kawai H; Shimagaki T; Yoshikawa S; Aoki Y; Osawa Y; Yoshida Y; Arai T; Itokawa N; Atsukawa M; Ito T; Honda T; Mise Y; Ono Y; Takahashi Y; Saiura A; Taketomi A; Kanto T
    Front Immunol; 2021; 12():603133. PubMed ID: 33692781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Panoramic comparison between NK cells in healthy and cancerous liver through single-cell RNA sequencing.
    Liu H; Zhao R; Qin R; Sun H; Huang Q; Liu L; Tian Z; Nashan B; Sun C; Sun R
    Cancer Biol Med; 2022 Jul; 19(9):1334-51. PubMed ID: 35856557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.
    Saini P; Adeniji OS; Bordoloi D; Kinslow J; Martinson J; Parent DM; Hong KY; Koshy J; Kulkarni AJ; Zilberstein NF; Balk RA; Moy JN; Giron LB; Tracy RP; Keshavarzian A; Muthumani K; Landay A; Weiner DB; Abdel-Mohsen M
    mBio; 2023 Feb; 14(1):e0339322. PubMed ID: 36728420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD56
    Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
    Front Immunol; 2019; 10():14. PubMed ID: 30761123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients.
    Cai L; Zhang Z; Zhou L; Wang H; Fu J; Zhang S; Shi M; Zhang H; Yang Y; Wu H; Tien P; Wang FS
    Clin Immunol; 2008 Dec; 129(3):428-37. PubMed ID: 18824414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cells.
    Hu J; Wang E; Liu L; Wang Q; Xia D; Bai W; Tie J; Li X; Yuan J; Yang S; Jiang D; Shi J; Sun Y; Wang J; Zhang C; Niu J; Li K; He C; Guo W; Lv Y; Chen H; Yuan X; Yu T; Wang Z; Luo B; Han N; Zhu Y; Yin Z; Fan D; Zhang Z; Yang K; Han G
    Invest New Drugs; 2020 Oct; 38(5):1247-1256. PubMed ID: 31832851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
    Morel E; Bellón T
    J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoring NK cells functionality via cytokine activation enhances cetuximab-mediated NK-cell ADCC: A promising therapeutic tool for HCC patients.
    Mahgoub S; Abosalem H; Emara M; Kotb N; Maged A; Soror S
    Mol Immunol; 2021 Sep; 137():221-227. PubMed ID: 34284214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IVIG induces apoptotic cell death in CD56
    Bunk S; Ponnuswamy P; Trbic A; Malisauskas M; Anderle H; Weber A; Ilas J; Winkler AM; Butterweck HA; Teschner W; Scheiflinger F; Hermann C; Reipert BM
    Clin Immunol; 2019 Jan; 198():62-70. PubMed ID: 30389480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1.
    Park DJ; Sung PS; Kim JH; Lee GW; Jang JW; Jung ES; Bae SH; Choi JY; Yoon SK
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32221015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of Human Hepatic Intrasinusoidal CD56
    Hwang S; Han J; Baek JS; Tak E; Song GW; Lee SG; Jung DH; Park GC; Ahn CS; Kim N
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased oxidative stress contributes to impaired peripheral CD56
    Lu Z; Tian Y; Bai Z; Liu J; Zhang Y; Qi J; Jin M; Zhu J; Li X
    Arthritis Res Ther; 2022 Feb; 24(1):48. PubMed ID: 35172900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure recovery of circulating NKG2D
    Gao J; Duan Z; Zhang L; Huang X; Long L; Tu J; Liang H; Zhang Y; Shen T; Lu F
    Oncoimmunology; 2016; 5(1):e1048061. PubMed ID: 26942056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of inhibitory receptors in natural killer (CD3(-)CD56(+)) cells and CD3(+)CD56(+) cells in the peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with primary hepatocellular carcinoma.
    Yuen MF; Norris S
    Clin Immunol; 2001 Dec; 101(3):264-9. PubMed ID: 11726217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired circulating CD56
    Jiang Y; Chen Y; Chen L; Yao W; Guan J; Liu X; Wei X; Lin X
    Hum Immunol; 2020 Jan; 81(1):32-40. PubMed ID: 31735440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Huth TK; Staines D; Marshall-Gradisnik S
    J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.